Natural Alternatives International (NAII) Common Stock USD0.01

Sell:$4.00Buy:$5.37$0.14 (3.37%)

NASDAQ:2.20%
Market closed | Prices delayed by at least 15 minutes
Sell:$4.00
Buy:$5.37
Change:$0.14 (3.37%)
Market closed | Prices delayed by at least 15 minutes
Sell:$4.00
Buy:$5.37
Change:$0.14 (3.37%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer’s preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.

Key people

Mark A. Ledoux
Chairman of the Board of Directors, Chief Executive Officer
Kenneth Eugene Wolf
President, Chief Operating Officer, Secretary
Michael E. Fortin
Chief Financial Officer
Alan G. Dunn
Independent Director
Laura Kay Matherly
Independent Director
Guru Ramanathan
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US6388423021
  • Market cap
    $25.72m
  • Employees
    296
  • Shares in issue
    9.48m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.